Verition Fund Management
AZN icon

Verition Fund Management’s AstraZeneca AZN Stock Holding History

Verition Fund Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-61,100
Closed -$7.12M – 2715
2021
Q4 		$7.12M Sell
61,100
-80,400
-57% -$9.46M 0.05% 249
2021
Q3 		$17M Sell
141,500
-34,200
-19% -$3.98M 0.15% 102
2021
Q2 		$21M Buy
175,700
+7,950
+5% +$872K 0.19% 80
2021
Q1 		$16.7M Buy
167,750
+125,250
+295% +$12.6M 0.19% 75
2020
Q4 		$4.25M Buy
+42,500
New +$4.5M 0.04% 229

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Verition Fund Management's AZN Position: Q1 2026 in Review

Verition Fund Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 2,589 shares — an estimated $476K sold.

Verition Fund Management first reported a position in AZN in Q2 2013 and held it in 23 quarters. The position peaked at $160M in Q3 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Verition Fund Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 2,589 AstraZeneca shares in Q1 2026, an estimated $476K.
  • Verition Fund Management first reported a position in AstraZeneca in Q2 2013 and held it in 23 quarters.
  • Verition Fund Management's AstraZeneca position peaked at $160M in Q3 2021.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.